Patients in cardiogenic shock with significant mitral regurgitation (MR) appear to fare well in the short term when treated with transcatheter edge-to-edge repair (TEER), according to a new ...
Windtree Therapeutics, Inc. announced that it is preparing for an interim analysis of its SEISMiC C Phase 2 study of istaroxime, targeting results for July 2025. This global, placebo-controlled, ...
DETROIT (December 13, 2023) – Published results of a large, national heart attack study show that patients with a life-threatening complication known as cardiogenic shock survived at a significantly ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results